Influenza A virus H7N9 vaccine nanopatch(Vaxxas)

N/A

Report date: 2025/05/08 17:52:50

Base Information

Drug NameInfluenza A virus H7N9 vaccine nanopatch(Vaxxas)
Drug Alias NameInfluenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray PatchVXS-1219
ClassificationVaccines > Biological material > Viral vaccineVaccines > Vaccine type > Univalent vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVaxxas Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVaxxas Pty Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A